Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The retention of both HBG genes, each with slightly different promoter sequences, also contributes to nuanced regulatory control and may influence HbF levels in adults, a feature of clinical relevance in disorders like β-thalassemia and sickle cell disease [97].”
From Origin and Evolution of Genes in Eukaryotes: Mechanisms, Dynamics, and Functional Implications (2025) · cites this paper as [97]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [17]
In the citing paper
“current treatments aim to induce the expression of non-mutated fetal hemoglobin (HbF), which is functional but transcriptionally repressed post-birth (Sankaran et al. 2008).”
From From serendipity to strategy: molecular glue degraders in cancer therapeutics (2025) · cites this paper as Sankaran et al. 2008
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
In the citing paper
“We identi fi ed numerous peptides of BCL11A and nearly all previously established interacting proteins, including FOG1, the entire NuRD complex, and the nuclear matrix protein MATRIN-3 (4).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Self-citationA Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., et al. (2007) · Nature · doi:10.1038/nature06014 · Cited by 1,604
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889
Tsai, S.-F., Martin, D. I. K., Zon, L. I., D'Andrea, A. D., Wong, G. G., & Orkin, S. H. (1989) · Nature · doi:10.1038/339446a0 · Cited by 885
Self-citationTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 504
Cited by
Items 201–300 of 1,001
Ma, Y., Liu, S., Gao, J., Chen, C., Zhang, X., Yuan, H., Chen, Z., Yin, X., Sun, C., Mao, Y., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.019 · Cited by 66
Self-citationThalassemias: from gene to therapy
Simone, G. D., Quattrocchi, A., Mancini, B., di Masi, A., Nervi, C., & Ascenzi, P. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101028 · Cited by 66
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
Norton, L. J., Funnell, A. P. W., Burdach, J., Wienert, B., Kurita, R., Nakamura, Y., Philipsen, S., Pearson, R. C. M., Quinlan, K. G. R., & Crossley, M. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002303 · Cited by 65
Yu, X., Azzo, A., Bilinovich, S. M., Li, X., Dozmorov, M. G., Kurita, R., Nakamura, Y., Williams, D. C., & Ginder, G. D. (2019) · Haematologica · doi:10.3324/haematol.2018.210963 · Cited by 65
Jawaid, K., Wahlberg, K., Thein, S. L., & Best, S. (2010) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.05.006 · Cited by 64
Hemoglobin S Polymerization and Red Cell Membrane Changes
Kuypers, F. A. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.12.002 · Cited by 64
Cánovas, J., Berndt, F. A., Sepúlveda, H., Aguilar, R., Veloso, F. A., Montecino, M., Oliva, C., Maass, J. C., Sierralta, J., & Kukuljan, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-15.2015 · Cited by 63
Thalassemia an update: molecular basis, clinical features and treatment
Tari, K., Ardalan, P. V., Abbaszadehdibavar, M., Atashi, A., Jalili, A., & Gheidishahran, M. (2018) · International Journal of Biomedicine and Public Health · doi:10.22631/ijbmph.2018.56102 · Cited by 63
Reactivation of a developmentally silenced embryonic globin gene
King, A. J., Songdej, D., Downes, D. J., Beagrie, R. A., Liu, S., Buckley, M., Peng, H., Suciu, M., Oudelaar, A. M., Hanssen, L. L. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24402-3 · Cited by 62
Self-citationHIC2 controls developmental hemoglobin switching by repressing BCL11A transcription
Huang, P., Peslak, S. A., Ren, R., Khandros, E., Qin, K., Keller, C. A., Giardine, B. M., Bell, H. W., Lan, X., Sharma, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01152-6 · Cited by 63
Pule, G. D., Mowla, S., Novitzky, N., & Wonkam, A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0092-7 · Cited by 62
Bjurström, C. F., Mojadidi, M., Phillips, J., Kuo, C., Lai, S., Lill, G. R., Cooper, A., Kaufman, M., Urbinati, F., Wang, X., et al. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.52 · Cited by 55
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Self-citationKhandros, E., & Kwiatkowski, J. L. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.01.003 · Cited by 61
Development of gene therapy for blood disorders: an update
Nienhuis, A. W. (2013) · Blood · doi:10.1182/blood-2013-04-453209 · Cited by 61
Migliaccio, A. R. (2010) · Haematologica · doi:10.3324/haematol.2010.033225 · Cited by 61
Fetal hemoglobin in sickle cell anemia: The Arab‐Indian haplotype and new therapeutic agents
Habara, A. H., Mohammed, E. S. E., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24872 · Cited by 60
Kiefer, C. M., Lee, J., Hou, C., Dale, R. K., Lee, Y. T., Meier, E. R., Miller, J. L., & Dean, A. (2011) · Blood · doi:10.1182/blood-2011-06-363101 · Cited by 59
Causal modelling of gene effects from regulators to programs to traits
Ota, M., Spence, J. P., Zeng, T., Dann, E., Milind, N., Marson, A., & Pritchard, J. K. (2025) · Nature · doi:10.1038/s41586-025-09866-3 · Cited by 59
Jiang, B., Zhang, X., Su, J., Meng, W., Yang, X., Yang, J., Zhou, Q., Chen, Z., Chen, Z., Xie, Z., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-61 · Cited by 59
Leighton, G. O., & Williams, D. C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.007 · Cited by 59
Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice
Esteghamat, F., Gillemans, N., Bilic, I., van den Akker, E., Cantù, I., van Gent, T., Klingmüller, U., van Lom, K., von Lindern, M., Grosveld, F., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434530 · Cited by 51
Trakarnsanga, K., Wilson, M. C., Griffiths, R. E., Toye, A. M., Carpenter, L., Heesom, K. J., Parsons, S. F., Anstee, D. J., & Frayne, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100874 · Cited by 58
Li, G., Diogo, D., Wu, D., Spoonamore, J., Dancik, V., Franke, L., Kurreeman, F., Rossin, E. J., Duclos, G., Hartland, C., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003487 · Cited by 55
Rivers, A. E., Vaitkus, K., Ibanez, V., Ruiz, M. A., Jagadeeswaran, R., Saunthararajah, Y., Cui, S., Engel, J. D., DeSimone, J., & Lavelle, D. (2016) · Haematologica · doi:10.3324/haematol.2015.140749 · Cited by 58
Adenovirus vectors in hematopoietic stem cell genome editing
Li, C., & Lieber, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13668 · Cited by 58
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Ferrari, S., Vavassori, V., Canarutto, D., Jacob, A., Castiello, M. C., Omer, A., & Genovese, P. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618378 · Cited by 57
2015 Clinical trials update in sickle cell anemia
Archer, N. M., Galactéros, F., & Brugnara, C. (2015) · American Journal of Hematology · doi:10.1002/ajh.24116 · Cited by 58
Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex
Gabbianelli, M., Testa, U., Morsilli, O., Pelosi, E., Saulle, E., Petrucci, E., Castelli, G., Giovinazzi, S., Mariani, G., Fiori, M. E., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.018259 · Cited by 57
Fujita, A., Uchida, N., Haro‐Mora, J. J., Winkler, T., & Tisdale, J. F. (2016) · Stem Cells · doi:10.1002/stem.2335 · Cited by 57
Antoniani, C., Romano, O., & Miccio, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0192 · Cited by 57
Discovering human diabetes-risk gene function with genetics and physiological assays
Peiris, H. S., Park, S., Louis, S., Gu, X., Lam, J. Y., Asplund, O., Ippolito, G. C., Bottino, R., Groop, L., Tucker, H. O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06249-3 · Cited by 58
Role of the GATA-1/FOG-1/NuRD Pathway in the Expression of Human β-Like Globin Genes
Miccio, A., & Blobel, G. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-10 · Cited by 46
Takase, S., Hiroyama, T., Shirai, F., Maemoto, Y., Nakata, A., Arata, M., Matsuoka, S., Sonoda, T., Niwa, H., Sato, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35404-0 · Cited by 56
Ulirsch, J. C., Lacy, J. N., An, X., Mohandas, N., Mikkelsen, T. S., & Sankaran, V. G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004890 · Cited by 48
Self-citationBCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression
Gasparello, J., Fabbri, E., Bianchi, N., Breveglieri, G., Zuccato, C., Borgatti, M., Gambari, R., & Finotti, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122530 · Cited by 56
MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
Li, Y., Zhu, X., Ward, C. M., Starlard‐Davenport, A., Takezaki, M., Berry, A., Ward, A., Wilder, C., Neunert, C. E., Kutlar, A., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.002 · Cited by 56
A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
Shen, F., Zheng, G., Setegne, M. T., Tenglin, K., Izadi, M., Xie, H. T. H., Zhai, L., Orkin, S. H., & Dassama, L. M. K. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00998 · Cited by 55
Self-citationHan, W., Qiu, H.-Y., Sun, S., Fu, Z.-C., Wang, G., Qian, X., Wang, L., Zhai, X., Jia, W. P., Wang, Y., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.10.007 · Cited by 55
Rivers, A. E., Vaitkus, K., Ruiz, M. A., Ibañez, V., Jagadeeswaran, R., Kouznetsova, T., DeSimone, J., & Lavelle, D. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.04.005 · Cited by 55
de Vasconcellos, J. F., Tumburu, L., Byrnes, C., Lee, Y. T., Xu, P. C., Li, M., Rabel, A., Clarke, B. A., Guydosh, N. R., Proia, R. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609552114 · Cited by 56
Smarca5-mediated epigenetic programming facilitates fetal HSPC development in vertebrates
Ding, Y., Wang, W., Ma, D., Liang, G., Kang, Z., Xue, Y., Zhang, Y., Wang, L., Heng, J., Zhang, Y., et al. (2020) · Blood · doi:10.1182/blood.2020005219 · Cited by 54
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis
Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37484 · Cited by 54
Funnell, A. P. W., Mak, K. S., Twine, N. A., Pelka, G. J., Norton, L. J., Radziewic, T., Power, M., Wilkins, M. R., Bell-Anderson, K. S., Fraser, S. T., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00074-13 · Cited by 54
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
Sripichai, O., & Fucharoen, S. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1255142 · Cited by 54
Ma, Y., Wang, B., Jiang, F., Wang, D., Liu, H., Yan, Y., Dong, H., Wang, F., Gong, B., Zhu, Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00623-13 · Cited by 54
Recent Advances in β-Thalassemias
Cao, A., Moi, P., & Galanello, R. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e17 · Cited by 53
Fetal Hemoglobin Induction by Epigenetic Drugs
Lavelle, D., Engel, J. D., & Saunthararajah, Y. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.008 · Cited by 53
Krüppel‐like factor 1: hematologic phenotypes associated with KLF1 gene mutations
Waye, J. S., & Eng, B. (2015) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12356 · Cited by 53
DNA Dynamics and Single-Molecule Biology
Duzdevich, D., Redding, S., & Greene, E. C. (2014) · Chemical Reviews · doi:10.1021/cr4004117 · Cited by 52
Li, X., Jia, S., Wang, S., Wang, Y., & Meng, A. (2009) · Blood · doi:10.1182/blood-2009-06-227777 · Cited by 52
Strict in vivo specificity of the Bcl11a erythroid enhancer
Smith, E. C., Luc, S., Croney, D. M., Woodworth, M. B., Greig, L. C., Fujiwara, Y., Nguyen, M., Sher, F., Macklis, J. D., Bauer, D. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-736249 · Cited by 48
Self-citationChi, K. R. (2009) · Nature · doi:10.1038/461712a · Cited by 52
Evolution of hemoglobin loci and their regulatory elements
Philipsen, S., & Hardison, R. C. (2018) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2017.08.001 · Cited by 51
Genome editing in large animal models
Maynard, L. H., Humbert, O., Peterson, C. W., & Kiem, H. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.026 · Cited by 51
Fetal globin expression is regulated by Friend of Prmt1
van Dijk, T. B., Gillemans, N., Pourfarzad, F., van Lom, K., Lindern, M. V., Grosveld, F. G., & Philipsen, S. (2010) · Blood · doi:10.1182/blood-2010-03-274399 · Cited by 51
Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation
Bottardi, S., Zmiri, F. A., Bourgoin, V., Ross, J., Mavoungou, L., & Milot, E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1271 · Cited by 40
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
Shariati, L., Khanahmad, H., Salehi, M., Hejazi, Z., Rahimmanesh, I., Tabatabaiefar, M. A., & Modarressi, M. H. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2928 · Cited by 51
The genetics of human hematopoiesis and its disruption in disease
Bao, E. L., Cheng, A. N., & Sankaran, V. G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910316 · Cited by 42
Self-citationWintering, A., Dvorak, C. C., Stieglitz, E., & Loh, M. L. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005117 · Cited by 51
Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative
Rueda, J., Beriaín, Í. D. M., & Montoliu, L. (2024) · The CRISPR Journal · doi:10.1089/crispr.2024.0042 · Cited by 50
Reversing the Hemoglobin Switch
Sankaran, V. G., & Nathan, D. G. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1010767 · Cited by 50
Self-citationShearstone, J. R., Golonzhka, O., Chonkar, A., Tamang, D., van Duzer, J. H., Jones, S. S., & Jarpe, M. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153767 · Cited by 50
Lai, K., Jia, S., Yu, S., Luo, J., & He, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18263 · Cited by 50
Transcriptional Mechanisms Underlying Hemoglobin Synthesis
Katsumura, K. R., DeVilbiss, A., Pope, N. J., Johnson, K. D., & Bresnick, E. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015412 · Cited by 50
Hemoglobin genetics: recent contributions of GWAS and gene editing
Smith, E. C., & Orkin, S. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw170 · Cited by 45
Self-citationSIRT1 activates the expression of fetal hemoglobin genes
Dai, Y., Chen, T., Ijaz, H., Cho, E. H., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24879 · Cited by 49
Novel genetic therapeutic approaches for modulating the severity of β‑thalassemia (Review)
Amjad, F., Fatima, T., Fayyaz, T., Khan, M. J., & Qadeer, M. I. (2020) · Biomedical Reports · doi:10.3892/br.2020.1355 · Cited by 49
Zhu, X., Wang, Y., Pi, W., Liu, H., Wickrema, A., & Tuan, D. Y. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047175 · Cited by 50
Recent trends for novel options in experimental biological therapy of β-thalassemia
Finotti, A., & Gambari, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927434 · Cited by 48
Chen, D., Zuo, Y., Zhang, X., Ye, Y., Bao, X., Huang, H., Tepakhan, W., Wang, L., Ju, J., Chen, G., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.012 · Cited by 48
Banan, M., Bayat, H., Azarkeivan, A., Mohammadparast, S., Kamali, K., Farashi, S., Bayat, N., Khani, M. H., Neishabury, M., & Najmabadi, H. (2012) · Hemoglobin · doi:10.3109/03630269.2012.691147 · Cited by 48
Shang, S., Li, X., Azzo, A., Truong, T., Dozmorov, M. G., Lyons, C. E., Manna, A. K., Williams, D. C., & Ginder, G. D. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302254120 · Cited by 47
Whole genome association studies in complex diseases: where do we stand?
Need, A. C., & Goldstein, D. B. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/aneed · Cited by 40
Clinical genome editing to treat sickle cell disease—A brief update
Zarghamian, P., Klermund, J., & Cathomen, T. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1065377 · Cited by 47
Role of ZBP-89 in human globin gene regulation and erythroid differentiation
Woo, A. J., Kim, J., Xu, J., Huang, H., & Cantor, A. B. (2011) · Blood · doi:10.1182/blood-2011-03-341446 · Cited by 46
Self-citationTranslating CRISPR-Cas Therapeutics: Approaches and Challenges
Tay, L. S., Palmer, N. D., Panwala, R., Chew, W. L., & Mali, P. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0025 · Cited by 47
Choudhuri, A., Trompouki, E., Abraham, B. J., Colli, L. M., Kock, K. H., Mallard, W., Yang, M.-L., Vinjamur, D. S., Ghamari, A., Sporrij, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00738-2 · Cited by 46
Self-citationDual function NFI factors control fetal hemoglobin silencing in adult erythroid cells
Qin, K., Huang, P., Feng, R., Keller, C. A., Peslak, S. A., Khandros, E., Saari, M. S., Lan, X., Mayuranathan, T., Doerfler, P. A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01076-1 · Cited by 46
EVI1 drives leukemogenesis through aberrant ERG activation
Schmoellerl, J., Barbosa, I. A. M., Minnich, M., Andersch, F., Smeenk, L., Havermans, M., Eder, T., Neumann, T., Jude, J., Fellner, M., et al. (2022) · Blood · doi:10.1182/blood.2022016592 · Cited by 46
Kuo, T., Hong, C., Chien, H., & Hsueh, Y. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22407 · Cited by 46
Sickle Cell Disease at 100 Years
Orkin, S. H., & Higgs, D. R. (2010) · Science · doi:10.1126/science.1194035 · Cited by 46
Self-citationThe emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia
Thein, S. L. (2012) · Blood Reviews · doi:10.1016/s0268-960x(12)70011-5 · Cited by 45
The transcriptional repressor BCL11A promotes breast cancer metastasis
Seachrist, D. D., Hannigan, M. M., Ingles, N. N., Webb, B. M., Weber-Bonk, K. L., Yu, P., Bebek, G., Singh, S., Sizemore, S. T., Varadan, V., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014018 · Cited by 45
The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease
Adekile, A. D. (2020) · Medical Principles and Practice · doi:10.1159/000511342 · Cited by 45
Mehta, S., Buyanbat, A., Yan, K., Karayel, Ö., Goldman, S. R., Seruggia, D., Zhang, K., Fujiwara, Y., Donovan, K. A., Zhu, Q., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.06.007 · Cited by 45
Self-citationHuman fetal globin gene expression is regulated by LYAR
Ju, J., Wang, Y., Liu, R., Zhang, Y., Xu, Z., Wang, Y., Wu, Y.-P., Liu, M., Cerruti, L., Zou, F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku718 · Cited by 45
Locus-Specific Proteomics by TChP: Targeted Chromatin Purification
Pourfarzad, F., Aghajanirefah, A., de Boer, E., ten Have, S., van Dijk, T. B., Kheradmandkia, S., Stadhouders, R., Thongjuea, S., Soler, É., Gillemans, N., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.004 · Cited by 44
Humbert, O., Peterson, C. W., Norgaard, Z. K., Radtke, S., & Kiem, H.-P. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.005 · Cited by 43
Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Drysdale, C. M., Nassehi, T., Gamer, J., Yapundich, M., Tisdale, J. F., & Uchida, N. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.001 · Cited by 44
Sheehan, V., Crosby, J. R., Sabo, A., Mortier, N. A., Howard, T. A., Muzny, D. M., Dugan, S., Aygün, B., Nottage, K. A., Boerwinkle, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110740 · Cited by 44
Klein, F., Roux, J., Cvijetic, G., Rodrigues, P. F., von Muenchow, L., Lubin, R., Pelczar, P., Yona, S., Tsapogas, P., & Tussiwand, R. (2022) · Nature Immunology · doi:10.1038/s41590-022-01167-5 · Cited by 43
Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA
Hahn, C. K., & Lowrey, C. H. (2014) · Blood · doi:10.1182/blood-2014-03-564302 · Cited by 42
Macari, E. R., Schaeffer, E. K., West, R. J., & Lowrey, C. H. (2012) · Blood · doi:10.1182/blood-2012-07-443986 · Cited by 42
Clinical Features of β-Thalassemia and Sickle Cell Disease
McGann, P. T., Nero, A. C., & Ware, R. E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_1 · Cited by 42
Soni, S. (2020) · American Journal of Hematology · doi:10.1002/ajh.25909 · Cited by 41
Hahn, C. K., & Lowrey, C. H. (2013) · Blood · doi:10.1182/blood-2013-03-491043 · Cited by 42
Huang, J., Zhang, X., Liu, D., Wei, X., Shang, X., Xiong, F., Yu, L., Yin, X., & Xu, X. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.291 · Cited by 42
Chou, Y., Chen, R.-L., Lai, Z.-S., Song, J., Chao, Y., & Shen, C.-K. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00035-15 · Cited by 42
BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia
Sebastiani, P., Farrell, J. J., Alsultan, A., Wang, S., Edward, H. L., Shappell, H., Bae, H., Milton, J. N., Baldwin, C. T., Al-Rubaish, A. M., et al. (2015) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2015.01.001 · Cited by 41
Metadata
- Authors
- Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H.
- Affiliations
- Broad Institute (US)
- Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2008-12-19
- Volume
- 322
- Issue
- 5909
- Pages
- 1839-1842
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1968165696
- Semantic Scholar
- a52e99500fd26811a2ae248d6dce95e3152b5bb7
- Cited by
- 919
- References
- 27
- Citations by year
- 2026: 59 · 2025: 46 · 2024: 55 · 2023: 52 · 2022: 47 · 2021: 73 · 2020: 70 · 2019: 31 · 2018: 50 · 2017: 59 · 2016: 63 · 2015: 46 · 2014: 45 · 2013: 53 · 2012: 49
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (HL32262-26, P01HL032262, R01HL032259, HL32259-27)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- fetal hemoglobin, BCL11A, globin gene regulation, beta-globin gene cluster, sickle cell disease, beta-thalassemia, erythroid cells, therapeutic target
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, Erythroblasts, Erythropoiesis, Fetal Hemoglobin, Gene Expression Regulation, Multigene Family, Hemoglobinopathies, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Down-Regulation, Erythroid Precursor Cells, K562 Cells, Protein Isoforms, Polymorphism, Single Nucleotide, RNA Interference, Erythroid Cells, Cell Line, Tumor, GATA1 Transcription Factor, Mice, beta-Globins, gamma-Globins, Mi-2 Nucleosome Remodeling and Deacetylase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.